Integrated EPIC/CNV microarray with EpiSign analysis clinical trials

EpiSign International: Expanding Epigenomic Testing in Rare Disease

This study looks at a new way to diagnose rare diseases called EpiSign. It uses special blood tests to examine your DNA to help find answers for people who haven't yet received a diagnosis for their suspected rare condition. Researchers hope it will speed up diagnosis.